However, other studies have reached the opposite conclusion. Novo Nordisk's crown jewel is safe for now, and continues to drive its financial results higher. However, various potential headwinds ...

It also provides other contract manufacturing services. Novo Holdings, the investment firm that has a controlling interest in Novo Nordisk, signed a $16.5 billion deal to buy Catalent in February ...

In an exclusive interview, NBC News’ Megan Fitzgerald sits down with Novo Nordisk CEO Lars Fruergaard Jørgensen who helmed it all, and presses him on the high price, drug shortages, and long ...

The diabetes medicine Ozempic has been a veritable cash cow for Novo Nordisk (NYSE: NVO). The company's revenue, earnings, and stock price have been on a tear in recent years -- and no single drug ...

Berenberg Bank analyst Kerry Holford maintained a Hold rating on Novo Nordisk (0QIU – Research Report) today and set a price target of DKK975.00. The company’s shares closed yesterday at ...

Within Novo Nordisk's comprehensive business update to investors, attention latched onto early data for an oral obesity therapy that outperformed the company’s big-selling GLP-1 agonist Wegovy ...

The best blackout curtains not only block exterior light, making it easier to fall—and stay—asleep, but they can insulate. According to interior designer Audrey Scheck, one of the greatest ...

The best logo maker helps you craft the right branding for your business - even if you've never designed a logo before. Our team of expert reviewers have tested the best free logo makers and the ...

Bagmatic NOVO is our new blood collection monitor serving the special needs of mobile blood donations. As a light weight device with outstanding long battery life, it is developed to take a ...

The previous Paralympic logo incorporated the Tae-Geuk, which is a traditional Korean decorative motif. According to oriental philosophy, Tae-Geuk refers to the ultimate reality from which all things ...

NBC News' Meagan Fitzgerald sits down with Novo Nordisk CEO Lars Jorgenson in Denmark to discuss the high costs and limited supply of the company's popular weight loss drugs, Ozempic and Wegovy ...